SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

Correspondence Activity Detail

Summit Therapeutics Inc. (SMMT) (CIK 0001599298) (SMMT)
Activity window: Oct. 25, 2025 to Oct. 24, 2026

Back View Correspondence Compare Probe Scores Download Probe Score CSV

Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.

Probe Score Breakdown

Current total
2.0 / 10
Correspondence-letter component
2.0
AI sentiment component
0.0
Keyword-match component
0.0
Signal-match component
0.0
Notable 8-K modifier
0.0

The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Apr. 27, 2026. These dates describe different events.

Correspondence Filings
2
Keyword Matches
0
Latest Activity
Apr. 27, 2026
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Apr. 27, 2026 UPLOAD Neutral/Informational Low The SEC has completed its review of Summit Therapeutics Inc.'s Form 10-K for the fiscal year ended December 31, 2025. They remind the company that it is ultimately responsible for… Read Filing EDGAR
Apr. 16, 2026 CORRESP Concern from SEC Moderate The correspondence from Summit Therapeutics Inc. to the SEC addresses comments received regarding their Form 10-K for the fiscal year ended December 31, 2025. The SEC requested mo… Read Filing EDGAR
Apr. 2, 2026 UPLOAD Concern from SEC High The SEC has issued comments regarding Summit Therapeutics Inc.'s Form 10-K for the fiscal year ended December 31, 2025. They have requested additional information about the compan… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.